The Asian Scientist 100
Can Li
Institution
University of Hong Kong
Country
Hong Kong
Field
Engineering
Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.
(Photo: University of Hong Kong)
AWARDS
- 2023 Croucher Tak Wah Mak Innovation Award
Related articles
Gutter Gold
What if the solution to the world's energy problem was lying in the gutter all along?
Winners Of The Asian Scientist Writing Prize 2017 Announced
A total of 26 winners received their prizes at the Asian Scientist Writing Prize 2017 held at the Science Centre Singapore.
WuXi AppTec And BioSolveIT Set Up Molecule Library
The GalaXi® platform grants researchers access to billions of virtual molecules, paving the way for faster drug discovery and development.
NTU And GlobalFoundries To Jointly Explore Next-Gen Memory Technology
The S$120 million partnership will see the development and deployment of a technology known as ReRAM, which boasts faster read and write speeds with lower power consumption than conventional RAMs.
China Approves Keytruda For Lung Cancer Treatment
Merck’s Keytruda is the first anti-PD-1 therapy to be approved as monotherapy, and in combination with chemotherapy, for lung cancer patients in China.
A Molecular Sieve for Carbon Dioxide
An international team of researchers has developed a type of polymer that specifically traps carbon dioxide, which can then be converted into other organic compounds for use by industry.
Knocking Down The Barriers To Object Identification
Scientists in South Korea have developed a technique to identify objects by using the microphone, accelerometer and gyroscope of smartphones.
Different Languages Convey Information At Similar Rates
Researchers in Hong Kong have found that all languages convey information at similar rates, regardless of whether they are spoken faster or slower.
ASLAN And Bukwang Team Up To Develop Immune-Oncology Drugs
The joint venture has resulted in the independent company JAGUAHR Therapeutics, which will focus on developing aryl hydrocarbon receptor antagonists for cancer treatment.